Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company PegBio Co. Ltd.
DescriptionL acting GLP-1 analogue
Molecular Target Glucagon-like peptide-1 (GLP-1)
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationDiabetes
Indication DetailsTreat Type II diabetes
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today